PrimeCell Therapeutics LLC Partners With Regeneration Technologies Inc. To Co-Develop Stem Cell Product For Orthopedic Applications

IRVINE, Calif.--(BUSINESS WIRE)--Aug. 23, 2006--PrimeCell(TM) Therapeutics LLC (www.primecelltherapeutics.com) today announced an agreement with Regeneration Technologies, Inc. (RTI) (Nasdaq:RTIX), the Florida-based processor of orthopedic, cardiovascular and other biologic implants, to pursue orthopedic applications using PrimeCell(TM) Therapeutics’ germ cell reprogramming technology.